Literature DB >> 21921725

HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients.

Nadeera Sidique, Anita Kohli, Bhavana Shivakumar, Stephen Migueles, G Mani Subramanian, Susanna Naggie, Michael A Polis, Henry Masur, Shyam Kottilil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21921725      PMCID： PMC3175052          DOI： 10.1097/QAI.0b013e31822d463f

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  11 in total

1.  Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients.

Authors:  Pedro Castro; Montserrat Laguno; Meritxell Nomdedeu; Anna López; Montserrat Plana; Emilio Fumero; Teresa Gallart; Josep Mallolas; José M Gatell; Felipe García
Journal:  AIDS Res Hum Retroviruses       Date:  2007-07       Impact factor: 2.205

2.  Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.

Authors:  Arthur Y Kim; Thomas Kuntzen; Joerg Timm; Brian E Nolan; Melanie A Baca; Laura L Reyor; Andrew C Berical; Andrea J Feller; Kristin L Johnson; Julian Schulze zur Wiesch; Gregory K Robbins; Raymond T Chung; Bruce D Walker; Mary Carrington; Todd M Allen; Georg M Lauer
Journal:  Gastroenterology       Date:  2010-09-24       Impact factor: 22.682

3.  Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV.

Authors:  Stephen A Migueles; Mark Connors
Journal:  JAMA       Date:  2010-07-14       Impact factor: 56.272

4.  HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens.

Authors:  Hernan Valdez; Nicole L Carlson; Anthony B Post; Robert Asaad; Peter S Heeger; Michael M Lederman; Paul V Lehmann; Donald D Anthony
Journal:  AIDS       Date:  2002-05-24       Impact factor: 4.177

5.  Hepatitis C infection in HIV-1 natural viral suppressors.

Authors:  Mohammad M Sajadi; Nahzinine Shakeri; Rohit Talwani; Robert R Redfield
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

6.  Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus.

Authors:  Nadia Alatrakchi; Vincent Di Martino; Vincent Thibault; Brigitte Autran
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

7.  High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.

Authors:  Veronica D Gonzalez; Karolin Falconer; Kim G Blom; Olle Reichard; Birgitte Mørn; Alex Lund Laursen; Nina Weis; Annette Alaeus; Johan K Sandberg
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

8.  Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons.

Authors:  R A Lempicki; M A Polis; J Yang; M McLaughlin; C Koratich; D W Huang; B Fullmer; L Wu; C A Rehm; H Masur; H C Lane; K E Sherman; A S Fauci; S Kottilil
Journal:  J Infect Dis       Date:  2006-03-13       Impact factor: 5.226

9.  Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

Authors:  Raymond T Chung; Janet Andersen; Paul Volberding; Gregory K Robbins; Tun Liu; Kenneth E Sherman; Marion G Peters; Margaret J Koziel; Atul K Bhan; Beverly Alston; Dodi Colquhoun; Tom Nevin; George Harb; Charles van der Horst
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

10.  Hepatitis C viral kinetics during treatment with peg IFN-alpha-2b in HIV/HCV coinfected patients as a function of baseline CD4+ T-cell counts.

Authors:  Neumann U Avidan; Deborah Goldstein; Lynn Rozenberg; Mary McLaughlin; Peter Ferenci; Henry Masur; Maria Buti; Anthony S Fauci; Michael A Polis; Shyam Kottilil
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12-01       Impact factor: 3.731
View more
  2 in total

Review 1.  Organized immune cell interactions within tumors sustain a productive T-cell response.

Authors:  Maria A Cardenas; Nataliya Prokhnevska; Haydn T Kissick
Journal:  Int Immunol       Date:  2021-01-01       Impact factor: 4.823

2.  Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis.

Authors:  Zhonglan Wu; Lijia Cui; Weiming Zhao; Dongzhi Yang; Hui Chen; Ruiqing Wang; Xuemin Wang; Linqi Zhang; Tianhua He
Journal:  Virol J       Date:  2016-10-18       Impact factor: 4.099
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.